(Q35570956)

8 August 2017

1 reference

title

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.12.11.1821

26 March 2024

author name string

Saurabh Mehandru

1

1 reference

8 August 2017

Martin Markowitz

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/13543784.12.11.1821

1 reference

https://api.crossref.org/works/10.1517/13543784.12.11.1821

Expert Opinion on Investigational Drugs

26 March 2024

published in

1 reference

8 August 2017

volume

12

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

1821-1828

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

8 August 2017

1 reference

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Antiretroviral-drug resistance among patients recently infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class∇

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Principles and practice of HIV-protease inhibitor pharmacoenhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Identification of HTLV-I gag protease and its sequential processing of the gag gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.11.1821

Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease

21 January 2018

13

1 reference

https://api.crossref.org/works/10.1517/13543784.12.11.1821

Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1517/13543784.12.11.1821

26 March 2024

Identifiers

1 reference

8 August 2017

1 reference